Telehealth improves communication among children with autism, parents

The potential for telehealth to help with prescriptions, rehabilitation programs and other care-related issues excites many within the industry.

Now, a pilot study at Michigan State University in East Lansing used an online program to help parents of children with autism improve their child’s social communication.

Funded by the U.S. Department of Defense’s Congressionally Directed Medical Research Programs, the study consisted of 12 weekly self-directed online courses that practiced intervention techniques. Half the parents also received biweekly video coaching sessions from therapists.

Children in both groups improved social communication skills, though the children of the parents who received additional therapy made greater gains.

“We now have good preliminary evidence that telehealth can increase access to parent training interventions for families of young children with autism spectrum disorder,” said Brooke Ingersoll, lead investigator of the study and MSU associate professor. “The ultimate goal is to use these types of methods to assist parents who live in rural and medically underserved areas, underrepresented groups, and even countries that don’t have the infrastructure for more intensive service delivery.”

Parents in both groups also noted decreased stress, which Ingersoll noted is crucial because parents of children with autism often experience higher stress than others.

Telehealth has proven a valuable resource in caring for chronic diseases and increasing access to health information in other fields.

“The general idea of stepped-care is that you can have low-intensity, low-cost service available to all families in the form of self-directed parent training, and then parents who need more support in learning the intervention techniques can be provided with coaching via videoconferencing,” the study said.

See the full report and an accompanying video from MSU here.

""
Nicholas Leider, Managing Editor

Nicholas joined TriMed in 2016 as the managing editor of the Chicago office. After receiving his master’s from Roosevelt University, he worked in various writing/editing roles for magazines ranging in topic from billiards to metallurgy. Currently on Chicago’s north side, Nicholas keeps busy by running, reading and talking to his two cats.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.